期刊
AIDS PATIENT CARE AND STDS
卷 37, 期 4, 页码 192-198出版社
MARY ANN LIEBERT, INC
DOI: 10.1089/apc.2022.0225
关键词
retention; HIV care; study within a review; human immunodeficiency virus; randomized controlled trial
This study aims to describe the various definitions used for retention in HIV care in randomized controlled trials. A total of 50 trials between 2007 and 2021 were identified, with 59 different definitions for retention in care. The most commonly used characteristics were follow-up time and clinical visits.
People living with HIV (PLHIV) need lifelong medical care. However, retention in HIV care is not measured uniformly, making it challenging to compare or pool data. The objective of this study within a review (SWAR) is to describe the assortment of definitions used for retention in HIV care in randomized controlled trials (RCTs). We conducted a SWAR, drawing data from an overview of systematic reviews on interventions to improve the HIV care cascade. Ethics review was not required for this analysis of secondary data. We identified RCTs of interventions used to improve retention in care for PLHIV, including all age groups and extracted the definitions used and their characteristics. We identified 50 trials that measured retention published between 2007 and 2021 and provided 59 definitions for retention in care. The definitions consisted of nine different characteristics with follow-up time (n = 47), and clinical visits (n = 36) most used. The definitions of retention in HIV care are highly heterogeneous. In this study, we present the pros and cons of characteristics used to measure retention in HIV care.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据